Cover design Loss of CD9 associated with endometrial cancer cell invasion The front cover of Molecular Human Reproduction shows normal human endometrium (top) and endometrial cancers grade 1 (middle) and grade 3 (bottom) stained with haematoxylin and eosin (left) or anti-CD9 monoclonal antibody (right). The loss of CD9 expression during endometrial cancer progression appears to be associated with increased cancer cell invasion as the report by Park et al. (pages 719Ð725) also showed that anti-CD9 mAb stimulates the invasive properties of an endometrial cancer cell line. For further details, please see 719725.
[Table of Contents]